A Clinical Trial to study the mindfulness-based approach to exposure and response prevention to improve acceptability and outcomes.

Phase 3

Completed

• Conditions: Health Condition 1: F42- Obsessive-compulsive disorder

• Registration Number: CTRI/2021/10/037545
• Lead Sponsor: SHEIKH MOHAMMAD ASIF

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-11-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

1. Meet DSM-5 (American Psychiatric Association, 2013) diagnostic criteria for OCD based on the Mini International Neuropsychiatric Interview [MINI 7.0.0]

2. Participants should be stable on psychiatric medication for at least 3 months prior to consent

3. Participants with no plans for changing psychiatric medication during the study

4. Participants with mild to moderate severity of depression

5. Aged between 18-45 years and both genders

6. Able to understand, read and write Hindi or English

Exclusion Criteria

1. People with the history of an identified organic cause for their OCD symptoms

2. Participants falling in ICD-10 (DCR) diagnostic criteria for a psychotic disorder, post-traumatic stress disorder (PTSD), substance abuse/dependence

3. Diagnosed with learning disability

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mindfulness based Exposure and response prevention in comparison to Exposure and response prevention would lead to greater improvements in OCD symptom severity at post-intervention.Timepoint: 12 weeks-Post Assessment <br/ ><br>4 weeks- Follow up

Secondary Outcome Measures

Name	Time	Method
MB-EX/RP in comparison to EX/RP will have greater improvemnts in depression symptom severity, mental wellbeing, mindfulness and obsessive-compulsive beliefs.Timepoint: 12 weeks- Post Assessment <br/ ><br>4 weeks - Follow up